Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Quality of Chronic Kidney Disease Management in Canadian Primary Care.

Bello AK, Ronksley PE, Tangri N, Kurzawa J, Osman MA, Singer A, Grill AK, Nitsch D, Queenan JA, Wick J, Lindeman C, Soos B, Tuot DS, Shojai S, Brimble KS, Mangin D, Drummond N.

JAMA Netw Open. 2019 Sep 4;2(9):e1910704. doi: 10.1001/jamanetworkopen.2019.10704.

2.

A Population-Based Analysis of Quality Indicators in CKD.

Manns L, Scott-Douglas N, Tonelli M, Weaver R, Tam-Tham H, Chong C, Hemmelgarn B.

Clin J Am Soc Nephrol. 2017 May 8;12(5):727-733. doi: 10.2215/CJN.08720816. Epub 2017 Apr 4.

3.

Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial.

Harasemiw O, Drummond N, Singer A, Bello A, Komenda P, Rigatto C, Lerner J, Sparkes D, Ferguson TW, Tangri N.

Can J Kidney Health Dis. 2019 May 29;6:2054358119841611. doi: 10.1177/2054358119841611. eCollection 2019.

4.

Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.

Samal L, Wright A, Waikar SS, Linder JA.

BMC Nephrol. 2015 Oct 12;16:162. doi: 10.1186/s12882-015-0154-x.

5.

Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.

Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ.

Kaohsiung J Med Sci. 2012 Sep;28(9):477-83. doi: 10.1016/j.kjms.2012.04.004. Epub 2012 Jul 7.

6.

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.

Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.

7.

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Navaneethan SD, Akeroyd JM, Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Ballantyne C, Winkelmayer WC, Ramanathan V, Virani SS.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1842-1850. doi: 10.2215/CJN.03830318. Epub 2018 Nov 29.

8.

Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.

Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD; National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Am J Med. 2016 Feb;129(2):153-162.e7. doi: 10.1016/j.amjmed.2015.08.025. Epub 2015 Sep 25. Review.

9.

The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.

PMID:
23658247
10.

Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada.

Nash DM, Brimble S, Markle-Reid M, McArthur E, Tu K, Nesrallah GE, Grill A, Garg AX.

Can J Kidney Health Dis. 2017 May 23;4:2054358117703059. doi: 10.1177/2054358117703059. eCollection 2017.

11.

Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial.

Carroll JK, Pulver G, Dickinson LM, Pace WD, Vassalotti JA, Kimminau KS, Manning BK, Staton EW, Fox CH.

JAMA Netw Open. 2018 Oct 5;1(6):e183377. doi: 10.1001/jamanetworkopen.2018.3377.

12.

Development of an electronic health record-based chronic kidney disease registry to promote population health management.

Mendu ML, Ahmed S, Maron JK, Rao SK, Chaguturu SK, May MF, Mutter WP, Burdge KA, Steele DJR, Mount DB, Waikar SS, Weilburg JB, Sequist TD.

BMC Nephrol. 2019 Mar 1;20(1):72. doi: 10.1186/s12882-019-1260-y.

13.

Behavioural interventions for type 2 diabetes: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1.

14.

Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study.

Bello AK, Ronksley PE, Tangri N, Kurzawa J, Osman MA, Singer A, Grill A, Nitsch D, Queenan JA, Wick J, Lindeman C, Soos B, Tuot DS, Shojai S, Brimble S, Mangin D, Drummond N.

Kidney Int Rep. 2019 Jan 21;4(4):561-570. doi: 10.1016/j.ekir.2019.01.005. eCollection 2019 Apr.

15.

Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.

Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A.

Am J Kidney Dis. 2007 Nov;50(5):733-42.

PMID:
17954286
16.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2010 May;26(5):249-58. Review.

17.

Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.

Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N.

Am J Kidney Dis. 2013 Dec;62(6):1102-8. doi: 10.1053/j.ajkd.2013.07.013. Epub 2013 Sep 14.

18.

Quality of chronic kidney disease management in primary care: a retrospective study.

Van Gelder VA, Scherpbier-De Haan ND, De Grauw WJ, Vervoort GM, Van Weel C, Biermans MC, Braspenning JC, Wetzels JF.

Scand J Prim Health Care. 2016;34(1):73-80. doi: 10.3109/02813432.2015.1132885. Epub 2016 Feb 6.

19.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
20.

Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized Trial.

Tuot DS, McCulloch CE, Velasquez A, Schillinger D, Hsu CY, Handley M, Powe NR.

Am J Kidney Dis. 2018 Aug;72(2):168-177. doi: 10.1053/j.ajkd.2018.01.058. Epub 2018 Apr 23.

Supplemental Content

Support Center